SCYNEXIS, Inc. To Present At JMP Securities Healthcare Conference
Published: Jun 18, 2014
RESEARCH TRIANGLE PARK, N.C., June 18, 2014 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that Yves J. Ribeill, Ph.D., SCYNEXIS' President and Chief Executive Officer, will present at the 9th Annual JMP Securities Healthcare Conference at the Westin Grand Central Hotel in New York City on Tuesday, June 24, 2014, at 3:00 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.